DK1048668T3 - Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater - Google Patents

Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater

Info

Publication number
DK1048668T3
DK1048668T3 DK00108560T DK00108560T DK1048668T3 DK 1048668 T3 DK1048668 T3 DK 1048668T3 DK 00108560 T DK00108560 T DK 00108560T DK 00108560 T DK00108560 T DK 00108560T DK 1048668 T3 DK1048668 T3 DK 1048668T3
Authority
DK
Denmark
Prior art keywords
spray drying
riboflavin
drying process
spray granules
containing spray
Prior art date
Application number
DK00108560T
Other languages
English (en)
Inventor
Markus Nowotny
Jean-Claude Tritsch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238078&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1048668(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1048668T3 publication Critical patent/DK1048668T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/12Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
    • C07D475/14Benz [g] pteridines, e.g. riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00108560T 1999-04-30 2000-04-19 Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater DK1048668T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108476 1999-04-30

Publications (1)

Publication Number Publication Date
DK1048668T3 true DK1048668T3 (da) 2003-05-26

Family

ID=8238078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00108560T DK1048668T3 (da) 1999-04-30 2000-04-19 Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater

Country Status (16)

Country Link
US (1) US6723346B1 (da)
EP (1) EP1048668B2 (da)
JP (1) JP4965013B2 (da)
KR (1) KR100720202B1 (da)
CN (1) CN1198595C (da)
AT (1) ATE231864T1 (da)
AU (1) AU770320B2 (da)
BR (1) BR0002390A (da)
CA (1) CA2306502A1 (da)
DE (1) DE60001286T3 (da)
DK (1) DK1048668T3 (da)
ES (1) ES2189711T5 (da)
ID (1) ID25698A (da)
MX (1) MXPA00004185A (da)
NO (1) NO318219B1 (da)
TW (1) TWI253347B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
DE10317051A1 (de) * 2003-04-11 2004-10-21 Basf Ag Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform
ES2332787T3 (es) 2003-07-22 2010-02-12 Dsm Ip Assets B.V. Procedimiento para la purificacion de rivoflavina.
EP2107934B1 (en) * 2006-12-07 2019-11-20 FrieslandCampina Nederland B.V. Method and apparatus for spray drying
CN104961740B (zh) * 2015-06-02 2016-04-27 湖北广济药业股份有限公司 一种含核黄素的固体制剂及其制备方法
JP7443663B2 (ja) 2018-11-07 2024-03-06 ディーエスエム アイピー アセッツ ビー.ブイ. 改善された流動性を示す、リボフラビンを含有する薬剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE91686T1 (de) * 1987-09-18 1993-08-15 Hoffmann La Roche Neue form des riboflavins.
DE3819745A1 (de) * 1988-06-10 1989-12-14 Basf Ag Verfahren zur herstellung von auf mikrobiellem wege hergestelltem riboflavin in form von sprueh- oder mikrogranulaten
JP2634285B2 (ja) * 1989-03-28 1997-07-23 積水化学工業株式会社 放射性物質取扱所の被覆材用非灰分性樹脂組成物
DE3927810A1 (de) 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
DE4014262A1 (de) 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP2000112883A (ja) * 1998-09-24 2000-04-21 Internatl Business Mach Corp <Ibm> 情報処理方法、情報処理装置、情報処理プログラムを格納する記憶媒体
CA2282908A1 (en) 1998-10-19 2000-04-19 F. Hoffmann-La Roche Ag Purification and crystallization process for riboflavin
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules

Also Published As

Publication number Publication date
ES2189711T3 (es) 2003-07-16
EP1048668B1 (en) 2003-01-29
CA2306502A1 (en) 2000-10-30
EP1048668A2 (en) 2000-11-02
BR0002390A (pt) 2000-10-31
ES2189711T5 (es) 2010-07-28
DE60001286D1 (de) 2003-03-06
US6723346B1 (en) 2004-04-20
NO318219B1 (no) 2005-02-21
TWI253347B (en) 2006-04-21
CN1198595C (zh) 2005-04-27
DE60001286T2 (de) 2003-11-06
JP4965013B2 (ja) 2012-07-04
KR20010029668A (ko) 2001-04-06
CN1275375A (zh) 2000-12-06
ATE231864T1 (de) 2003-02-15
MXPA00004185A (es) 2002-03-08
EP1048668A3 (en) 2001-03-28
JP2000327562A (ja) 2000-11-28
NO20002283L (no) 2000-10-31
AU3018900A (en) 2000-11-02
NO20002283D0 (no) 2000-04-28
DE60001286T3 (de) 2010-10-28
EP1048668B2 (en) 2010-06-09
ID25698A (id) 2000-11-02
AU770320B2 (en) 2004-02-19
KR100720202B1 (ko) 2007-05-21

Similar Documents

Publication Publication Date Title
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
ZA200106370B (en) Process for the production of tert-butyl (E)-(6[2- [-4(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4R, 6S)-2,2-dimethyl [1,3]dioxan-4-yl)acetate.
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
DK0446913T3 (da) Fremgangsmåde til fremstilling af chlorthiazolderivater.
HUT64310A (en) Compositions containing substituted aryl-halogenalkyl-pyrazol derivatives having herbicidal activity and process for producing said compounds
FI102069B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi
DE60028436D1 (de) Verfahren zur Verbesserung der Viskositätsstabilität wässriger Verbindungen
HUT62893A (en) Process for producing substituted pyrimidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ATE64548T1 (de) Granuliertes produkt.
DK1048668T3 (da) Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater
WO1992020649A3 (en) Substituted 2-carboxyindoles having pharmaceutical activity
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
EP1571144A4 (en) HYDROXYALKYLATED CYCLIC DEDIAMINE COMPOUND
DE69833951D1 (de) Verfahren zur herstellung von substituierten alkylaminen oder salzen davon
IS1606B (is) Aðferð til framleiðslu nýs sýkladrepandi efnasambands Thiomarinol, fengið með ræktun Alteromanas rava SANK 73390
FR2799463B1 (fr) Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
FR2688503B1 (fr) Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1&#39;-biphenyle].
DE10195718D2 (de) Verfahren zum Herstellen von Objektion, Volumina, Möbelmodulen und Möbel sowie nach diesem Verfahren erzeugte Gegenstände
PT1325740E (pt) Granulados estaveis contendo s-adenosilmetionina e processo para a preparacao dos mesmos
DE50209196D1 (de) Verfahren zur herstellung von bleichaktivatorgranulaten
TH45468A (th) กระบวนการสำหรับการเตรียมวัสดุเม็ดหยาบสำหรับสเปรย์ซึ่งมีริโบฟลาวิน
NO20040423L (no) Salter av substituerte 1,2,3,4-tetrahydroisokinolin-2-karboksylsyrederivater.